Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismA central function for perlecan in skeletal muscle and cardiovascular developmentPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusionRoles of Proteoglycans and Glycosaminoglycans in Wound Healing and FibrosisThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyDecellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interactionExtracellular Matrix, a Hard Player in AngiogenesisA current view of perlecan in physiology and pathology: A mosaic of functions.The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts.Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in miceGenetic alterations in seborrheic keratoses.Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder.Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin.Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations.Pyogenic granuloma, an impaired wound healing process, linked to vascular growth driven by FLT4 and the nitric oxide pathway.Proteoglycans in Normal and Healing Skin.Perlecan maintains microvessel integrity in vivo and modulates their formation in vitroSNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressivenessA Molecular Predictor Reassesses Classification of Human Grade II/III GliomasStage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling.3D tissue-engineered model of Ewing's sarcomaAgrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.Epithelial basement membrane proteins perlecan and nidogen-2 are up-regulated in stromal cells after epithelial injury in human corneasEvolution of the perlecan/HSPG2 gene and its activation in regenerating Nematostella vectensisThe role of heparanase in pulmonary cell recruitment in response to an allergic but not non-allergic stimulus.Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing.Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesisThe role of heparan sulfate and perlecan in bone-regenerative procedures.Proteomic profiling of endorepellin angiostatic activity on human endothelial cellsProteoglycans in cancer biology, tumour microenvironment and angiogenesis.The extracellular matrix and blood vessel formation: not just a scaffold.Proteoglycans and their roles in brain cancer.Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis.Endothelial heparan sulfate in angiogenesis.The mutational landscape of adenoid cystic carcinomaDiverse cell signaling events modulated by perlecan.Perlecan expression influences the keratin 15-positive cell population fate in the epidermis of aging skin
P2860
Q21710680-1CB038E1-B15F-4281-ADA2-9C24C815A78AQ24303934-0C8CA461-55F1-4796-9E78-332B2BCBBDB5Q24648227-BEEE4359-FAEA-4302-9A36-E907B9D8D218Q24653433-886D0F2D-1858-4FF6-9684-C4E89547CC75Q24683770-D201ABEB-42FD-4A62-BCAC-F041C0046BB2Q26786042-B7B53692-C268-460D-AFEC-CE2413EC4690Q26800258-659344C5-22B1-4A1F-BEB1-BE071418F387Q27333526-90CD1532-AF76-4135-8E98-4AFE8936A5DAQ28072886-243238B3-50F2-483E-B15D-2994E8A2EE2DQ30392738-EEC54F7E-DB0A-4FA5-ABF7-BE0FC28606D1Q33304884-F7821CC8-B1D7-45C9-B8CC-A12F1A3F53C8Q33587338-6AFF890F-82CD-4454-8647-1D8F02A25620Q33829598-D55132E3-3DD9-400B-8177-5A98DB3AF4FEQ34036662-A0F7CFF7-F006-4B4D-95B0-9556D4C1966FQ34195733-13DE28E0-DA8F-4564-A551-395E3CF49036Q34258918-DC7EF952-F440-45FB-A9F2-936DE2F713D1Q34407465-C23EA7B2-AC74-456F-B98C-CCEAE1ADF7F5Q34467680-3A698552-2B0A-41B3-905A-CBC38E7586D4Q34548326-D300BDCF-4AFB-445E-8809-FF790ADD5E88Q34672464-64106F82-2F2B-4E5B-847A-FF66C9C9713CQ34785423-C414D7AC-180D-466A-A2C4-2EFB3A7C85FAQ35056355-ACDFDEC1-3C60-48DF-BAD0-195561F76053Q35428655-DB26B06E-05EC-490D-9F1B-CB2E3BBBE5FDQ35519929-B5BD0126-1B2E-4071-AFA1-F5848691F0C7Q35588817-A93DAF04-8E1A-4BD7-A723-A3B2769CFD84Q35602519-A50DE651-3091-46ED-A6C7-7D40D211C4C9Q35651533-8D19658F-7B82-40D2-AF3E-537D50EFB9D0Q35923316-579E2C64-0F12-474D-8284-D648D9CF47CDQ36011804-ED970260-F07A-4EA8-A956-CE6BF8533BFBQ36119681-C4D052A5-8EEF-459A-AA18-C5197FB81FDAQ36376753-AE036904-F6EF-4E66-BDE6-51BCAD74FF96Q36509450-C9E9391B-293D-478C-BF95-D1C98C7BB7F2Q36787608-1A931FCB-F408-4B0A-8AF6-6621A2E759E7Q36815331-D57CDD30-3F15-4C83-8357-94B750AE6547Q36816444-F7F22B46-7316-427D-8DE8-A8F468F509A9Q36893701-4F6375E6-F6DD-42B9-B17B-5D0711E9106BQ36989520-427E9F47-BB7E-49B6-BE40-AA6AD6F06B0DQ37003447-6983603D-A682-49B1-9D32-D15506E3B080Q37020797-3C7EA9AC-2690-4299-9E01-D4CF1B2BB0EFQ37049108-F4BC2F1F-45FB-421D-AB21-BF2CB7FFA2B8
P2860
Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@ast
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@en
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@nl
type
label
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@ast
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@en
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@nl
prefLabel
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@ast
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@en
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@nl
P2093
P50
P1433
P1476
Impaired angiogenesis, delayed ...... heparan sulfate-deficient mice
@en
P2093
Hiroyuki Morita
Jianming Wang
Karl Tryggvason
Raija Soininen
Renhai Cao
P304
P356
10.1158/0008-5472.CAN-04-0810
P407
P577
2004-07-01T00:00:00Z